Home > Pulmonology > NLC 2022 > Treatable Traits in Obstructive Airway Diseases > Targeting treatable traits allows a personalised approach to management of (severe) asthma

Targeting treatable traits allows a personalised approach to management of (severe) asthma

Presented By
Dr Florence Schleich, University of Liège, Belgium
Conference
NLC 2022
Doi
https://doi.org/10.55788/9a26835c
The concept of targeting “treatable traits” allows for a more holistic management of complex conditions. More recently, an expert panel proposed several pulmonary and extra-pulmonary treatable traits for (severe) asthma and COPD [1]. Dr Florence Schleich (University of Liège, Belgium) pleaded for a treatable traits approach to be applied more broadly in uncontrolled asthma. To avoid corticosteroids overtreatment and associated side effects, pheno/endotyping should be performed. Type 2/eosinophilic inflammation should be treated with targeted biologics and prominent airflow obstruction in the absence of inflammation should be adequately addressed with long-acting muscarinic antagonists [LAMA]/long-acting beta2-agonists [LABA], and/or thermoplasty. Lifestyle adjustments should be implemented: e.g. smoking cessation for smokers, weight loss and physical activity for overweight/obese patients. By identifying treatable traits in individual patients, a personali...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on